UPDATE : Friday, June 22, 2018
Sillajen unveils trial results for cancer treatment at US conference
Sillajen said Thursday that it has presented partial sections of its phase ...
by Lee Han-soo  |  2018-05-17 18:01
Sanofi Genzyme Korea gets 2nd line coverage for prostate cancer drug
Sanofi Genzyme Korea said Thursday that it got reimbursement for its prosta...
by Marian Chu  |  2018-05-17 18:01
KCDC finds Gram-negative bacteria infection in mass sepsis infection case
P. agglomerans A probe by the Korea Centers for Disease Control and Preve...
by Marian Chu  |  2018-05-17 18:01
Samsung BioLogics shares fall 4% ahead of FSC review over alleged accounting fraud
Shares of Samsung BioLogics fell 4 percent as officials from Samsung BioLog...
by Marian Chu  |  2018-05-17 18:00
SNUH conducts over 200 laparoscopic liver transplants
Seoul National University Hospital (SNUH) said Thursday that it has become ...
by Lee Han-soo  |  2018-05-17 18:00
Refusals of off-label drugs spiked last year
Government regulators’ refusals of off-label drugs surged last year. Off-la...
by Nam Doo-hyun  |  2018-05-17 15:23
Ildong, Olix agree to develop macular degeneration treatment
Ildong said Thursday that it has signed a cooperative agreement with Olix P...
by Lee Han-soo  |  2018-05-17 14:18
Hugel completes P1 clinical trial on hypertrophic scar treatment
Hugel said Wednesday that it has completed phase 1 clinical trials on BMT10...
by Lee Han-soo  |  2018-05-17 11:50
Dongwha, Hugel boost Q1 earnings under new CEO
Seven drugmakers with new CEOs this year showed mixed results in the first-...
by So Jae-hyeon  |  2018-05-17 11:45
Allergan Korea appoints Kim Ji-hyun as new CEO
Allergan appointed Kim Ji-hyun as the new CEO of its Korean offshoot. Kim h...
by Marian Chu  |  2018-05-17 11:36
US approves Daewoong’s Nabota plant
Daewoong Pharmaceutical said it got the U.S. Food and Drug Administration’s...
by Marian Chu  |  2018-05-16 18:34
Ministry approves Korea’s first AI-based medical device
The Ministry of Food and Drug Safety said Wednesday that it has approved VU...
by Lee Han-soo  |  2018-05-16 16:04
‘Biosimilars are better than originals’
“Biosimilars offer better quality than original drugs. This is a fact.”Jean...
by Park Gi-taek  |  2018-05-16 15:56
HIRA opens training program for Thailand health authorities
Health Insurance Review and Assessment Service (HIRA) completed a training ...
by Marian Chu  |  2018-05-16 15:21
Hanyang rheumatic disease hospital to focus on intractable diseases
Celebrating its 20th anniversary this year, Hanyang University Hospital for...
by So Jae-hyeon  |  2018-05-16 15:21
‘Proton therapy killed tumor in 70% of liver cancer patients’
Researchers from Samsung Medical Center have published a study that showed ...
by Marian Chu  |  2018-05-16 14:16
Jeil Pharma opens new tech research center
Jeil Pharmaceutical said Wednesday that it has opened a new technology rese...
by Lee Han-soo  |  2018-05-16 14:14
How China’s scrapping of tariffs will affect Korea’s drug exports?
Korean drug exporters are paying attention to how China’s exemption of impo...
by Nam Doo-hyun  |  2018-05-16 12:14
Celltrion posts ₩245 billion in Q1 sales thanks to biosimilar uptake
Celltrion recorded sales of 245 billion won ($227 million) in the first qua...
by Marian Chu  |  2018-05-16 12:13
Will Korean bio stocks rebound as MSCI includes Celltrion, Viromed, HLB?
Although the stocks of Korean biopharmaceutical companies plummeted followi...
by Marian Chu  |  2018-05-16 11:25
Back to Top